BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/6/2018 1:35:44 PM | Browse: 1008 | Download: 1250
 |
Received |
|
2018-09-01 04:11 |
|
Peer-Review Started |
|
2018-09-01 10:34 |
|
To Make the First Decision |
|
2018-10-15 01:54 |
|
Return for Revision |
|
2018-10-15 03:21 |
|
Revised |
|
2018-10-30 13:29 |
|
Second Decision |
|
2018-11-07 09:04 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2018-11-07 22:31 |
|
Articles in Press |
|
2018-11-07 22:31 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2018-11-28 03:44 |
|
Publish the Manuscript Online |
|
2018-12-06 13:35 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article which was selected byan in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Review |
| Article Title |
Biomarkers in colorectal cancer: Current clinical utility and future perspectives
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Marco Vacante, Antonio Maria Borzì, Francesco Basile and Antonio Biondi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Antonio Biondi, PhD, Full Professor, Department of General Surgery and Medical-Surgical Specialties, University of Catania, Azienda Ospedaliero - Universitaria "Policlinico - Vittorio Emanuele" Via Santa Sofia 76, Catania 95123, Italy. abiondi@unict.it |
| Key Words |
Biomarkers; Colorectal cancer; Epigenetics; Tumor markers; DNA methylation |
| Core Tip |
Colorectal cancer (CRC) is one of the leading causes of cancer death in the world today. Therefore, any improvement in early diagnosis, selection of appropriate treatment regimen, and effective follow up can be crucial in decreasing related mortalities. This review discusses the most useful and promising genetic and epigenetic biomarkers for CRC. There is growing evidence that these biomarkers could help future development of more personalized treatment approaches. |
| Publish Date |
2018-12-06 13:35 |
| Citation |
Vacante M, Borzì AM, Basile F, Biondi A. Biomarkers in colorectal cancer: Current clinical utility and future perspectives. World J Clin Cases 2018; 6(15): 869-881 |
| URL |
http://www.wjgnet.com/2307-8960/full/v6/i15/869.htm |
| DOI |
http://dx.doi.org/10.12998/wjcc.v6.i15.869 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
